Question about Williams Design [Design Issues]

posted by Bebac user – Egypt, 2025-02-25 21:30 (22 d 17:45 ago) – Posting: # 24376
Views: 303

Hello Dears,

Is this study design acceptable?

## Williams design ##

Three treatments, three phases and six sequences.

T1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.
T2.. Sitagliptin 100mg and Empagliflozin 25mg.
R1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.

Thanks in advance.

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,673 registered users;
14 visitors (0 registered, 14 guests [including 1 identified bots]).
Forum time: 15:15 CET (Europe/Vienna)

The best thing about being a statistician is
that you get to play in everyone’s backyard.    John W. Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5